Low-density lipoprotein cholesterol 4: the notable risk factor of coronary artery disease development

D Wu, Q Yang, B Su, J Hao, H Ma, W Yuan… - Frontiers in …, 2021 - frontiersin.org
Background: Coronary artery disease (CAD) is the leading cause of death worldwide, which
has a long asymptomatic period of atherosclerosis. Thus, it is crucial to develop efficient …

Development of Machine Learning Tools for Predicting Coronary Artery Disease in the Chinese Population

T Zhang, S Huang, P Xie, X Li, Y Pan, Y Xu… - Disease …, 2022 - Wiley Online Library
Purpose. Coronary artery disease (CAD) is one of the major cardiovascular diseases and
the leading cause of death globally. Blood lipid profile is associated with CAD early risk …

Low-density lipoprotein 4: a novel predictor of coronary artery disease severity

R Chaudhary, D Mathew, K Bliden… - … medical research and …, 2017 - Taylor & Francis
Background: Hyperlipidemia is a well established risk factor for coronary artery disease
(CAD). Severe CAD has been observed in patients with normal levels of total and low …

Low-density lipoprotein-associated variables and the severity of coronary artery disease: an untreated Chinese cohort study

X Zhao, D Sun, RX Xu, YL Guo, CG Zhu, NQ Wu… - Biomarkers, 2018 - Taylor & Francis
Background and aims: Elevated low-density lipoprotein cholesterol (LDL-C) is causal risk for
coronary artery disease (CAD) and LDL-associated variables including LDL-C …

[HTML][HTML] Association of Low-Density Lipoprotein-Cholesterol and Its Small, Dense Phenotype with Six-Month Cardiovascular Morbidity

S Ibrahim, A Udupi, C Rebeiro… - … of Biochemistry & …, 2022 - ncbi.nlm.nih.gov
Background: Globally, cardiovascular diseases (CVDs) are the leading cause of death and
disability. Elevated low-density lipoprotein-cholesterol (LDL-C) and more specifically …

Circulating non–HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease

CG Zhu, Y Zhang, RX Xu, S Li, NQ Wu, YL Guo… - Journal of clinical …, 2015 - Elsevier
Background Conflicting results have been yielded as to whether low-density lipoprotein
(LDL) cholesterol (LDL-C) or non–high-density lipoprotein (HDL) cholesterol (non–HDL-C) …

[HTML][HTML] Association of low-density lipoprotein cholesterol levels with the risk of mortality and cardiovascular events: A meta-analysis of cohort studies with 1,232,694 …

K Peng, X Li, Z Wang, M Li, Y Yang - Medicine, 2022 - journals.lww.com
Background: Lowering elevated low-density lipoprotein cholesterol (LDL-C) is an important
strategy to prevent cardiovascular disease (CVD), while some studies report low LDL-C …

LDL‐Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome

PA Field, RS Vasan - Clinical Pharmacology & Therapeutics, 2018 - Wiley Online Library
Coronary artery disease (CAD) is a progressive disorder and its risk is best determined
using multiple biomarkers and risk factors. Many novel biomarkers have been shown to …

Prediction of low-density lipoprotein cholesterol levels using machine learning methods

Y Kim, WK Lee, W Lee - Laboratory Medicine, 2024 - academic.oup.com
Objective Low-density lipoprotein cholesterol (LDL-C) has been commonly calculated by
equations, but their performance has not been entirely satisfactory. This study aimed to …

Comparison of a machine learning method and various equations for estimating low-density lipoprotein cholesterol in Korean populations

YJ Kwon, H Lee, SJ Baik, HJ Chang… - Frontiers in cardiovascular …, 2022 - frontiersin.org
Background LDL-C is the primary target of lipid-lowering therapy and used to classify
patients by cardiovascular disease risk. We aimed to develop a deep neural network (DNN) …